Management manual for cancer treatment-induced bone loss (CTIBL): position statement of the JSBMR Seiji FukumotoSatoshi Soenthe Subcommittee for CTIBL in the JSBMR Perspective 04 February 2020 Pages: 141 - 144
Bone: a key aspect to understand phenomena in clinical hematology Kanako WakahashiYoshio Katayama Review Article 02 January 2020 Pages: 145 - 150
Diffuse microdamage in bone activates anabolic response by osteoblasts via involvement of voltage-gated calcium channels Hyungjin JungOzan Akkus Original Article 06 September 2019 Pages: 151 - 160
Role of irisin in androgen-deficient muscle wasting and osteopenia in mice Shunki IemuraNaoyuki KawaoHiroshi Kaji Original Article 07 September 2019 Pages: 161 - 171
Skeletal changes during lactation and after weaning in osteocyte-specific sclerostin overexpressed mice Su Jin LeeSun Yong SongYumie Rhee Original Article 09 September 2019 Pages: 172 - 178
Effects of bazedoxifene and low-intensity aerobic exercise on bone and fat parameters in ovariectomized rats Yusuke YuasaNaohisa MiyakoshiYoichi Shimada Original Article 05 October 2019 Pages: 179 - 187
Mutation spectrum of COL1A1/COL1A2 screening by high-resolution melting analysis of Chinese patients with osteogenesis imperfecta Mingyan JuXue BaiGuang Li Original Article 14 August 2019 Pages: 188 - 197
Low serum 25-hydroxyvitamin D is associated with low grip strength in an older Japanese population Taeko KitsuKeiko KabasawaIchiei Narita Original Article 16 August 2019 Pages: 198 - 204
Bone fracture risk factors in prevalent hemodialysis patients Patrícia João MatiasIvo LaranjinhaAníbal Ferreira Original Article 05 September 2019 Pages: 205 - 212
Novel algorithm generating strategy to identify high fracture risk population using a hybrid intervention threshold Chung-Yuan HsuChih-Hsing WuTien-Tsai Cheng Original Article 03 October 2019 Pages: 213 - 221
Ten years change in post-fracture care for hip fracture patients Shun ShimodanDai SatoTomohiro Shimizu Original Article 03 October 2019 Pages: 222 - 229
Efficacy of non-steroidal anti-inflammatory drugs on zoledronic acid-induced acute-phase reactions: randomized, open-label, Japanese OZ study Nobukazu OkimotoAkinori SakaiSaeko Fujiwara Original Article 04 October 2019 Pages: 230 - 239
Effect of continuous long-term treatment for 10 years with bisphosphonate on Japanese osteoporosis patients Kousuke IbaJunichi TakadaToshihiko Yamashita Original Article 30 October 2019 Pages: 240 - 247
Factors affecting continuation of weekly teriparatide administration in rural areas Hiroyuki TsuchieNaohisa MiyakoshiYoichi Shimada Original Article 03 October 2019 Pages: 248 - 253
Zoledronic acid and skeletal-related events in patients with bone metastatic cancer or multiple myeloma Ha-Lim JeonIn-Sun OhJu-Young Shin Original Article 31 October 2019 Pages: 254 - 263
Papillary thyroid carcinoma is a risk factor for severe osteoporosis Masakazu NotsuMika YamauchiToshitsugu Sugimoto Original Article 29 October 2019 Pages: 264 - 270
Comparing directly measured versus mathematically calculated free serum 25-hydroxy vitamin D level in children Judith Sebestyen VanSickleTarak SrivastavaUri S. Alon Original Article 01 November 2019 Pages: 271 - 274
Correction to: The association of urinary pentosidine levels with the prevalence of osteoporotic fractures in postmenopausal women Masataka ShirakiShoji KashiwabaraMitsuru Saito Correction 19 November 2019 Pages: 275 - 275